Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Experimental Eye Research|July 8, 2020
Intravitreal enzyme replacement inhibits progression of retinal degeneration in canine CLN2 neuronal ceroid lipofuscinosisRebecca E H Whiting, Grace Robinson Kick, Juri Ota-Kuroki, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|September 23, 2025
Topical Application of a Novel Harderian-Derived Nonpolar Lipid Prolongs Tear Film Breakup Time in Normal Beagle DogsNayone L Lantyer-Araujo, Sangwan Park, Erin A Hisey, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|April 13, 2005
Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkeyDeeba Husain, Ivana Kim, Danny Gauthier, et al.
Molecular Genetics and Metabolism|April 13, 2011
Biodistribution and pharmacodynamics of recombinant human alpha-L-iduronidase (rhIDU) in mucopolysaccharidosis type I-affected cats following multiple intrathecal administrationsCharles H Vite, Ping Wang, Reema T Patel, et al.
Experimental Eye Research|July 5, 2020
Intravitreal enzyme replacement preserves retinal structure and function in canine CLN2 neuronal ceroid lipofuscinosisRebecca E H Whiting, Jacqueline W Pearce, Daniella P Vansteenkiste, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 5, 2015
Neutral endopeptidase-resistant C-type natriuretic peptide variant represents a new therapeutic approach for treatment of fibroblast growth factor receptor 3-related dwarfismDaniel J Wendt, Melita Dvorak-Ewell, Sherry Bullens, et al.
Experimental Eye Research|June 24, 2014
Enzyme replacement therapy delays pupillary light reflex deficits in a canine model of late infantile neuronal ceroid lipofuscinosisRebecca E H Whiting, Kristina Narfström, Gang Yao, et al.
Molecular Genetics and Metabolism|July 26, 2011
Intrathecal tripeptidyl-peptidase 1 reduces lysosomal storage in a canine model of late infantile neuronal ceroid lipofuscinosisBrian R Vuillemenot, Martin L Katz, Joan R Coates, et al.
Nucleic Acid Therapeutics|February 7, 2025
Targeting a Novel Site in Exon 51 with Antisense Oligonucleotides Induces Enhanced Exon Skipping in a Mouse Model of Duchenne Muscular DystrophyTodd Oppeneer, Yulan Qi, Joshua Henshaw, et al.
American Journal of Human Genetics|December 4, 2012
Evaluation of the therapeutic potential of a CNP analog in a Fgfr3 mouse model recapitulating achondroplasiaFlorence Lorget, Nabil Kaci, Jeff Peng, et al.
Pageof 5